We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+0.97%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$7.23B
AUM Growth
-$1.26B
(-15%)
Cap. Flow
-$1.29B
Cap. Flow
% of AUM
-17.85%
Top 10 Holdings %
Top 10 Hldgs %
17.57%
Holding
1,950
New
32
Increased
184
Reduced
1,428
Closed
301
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Equinix
EQIX
|
+$4.63M |
| 2 |
Consolidated Edison
ED
|
+$2.41M |
| 3 |
ProShares Global Listed Private Equity ETF
PEX
|
+$2.33M |
| 4 |
Sysco
SYY
|
+$2.07M |
| 5 |
Pentair
PNR
|
+$1.95M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$94.7M |
| 2 |
Microsoft
MSFT
|
+$47.6M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$38.2M |
| 4 |
Gilead Sciences
GILD
|
+$21.7M |
| 5 |
Meta Platforms (Facebook)
META
|
+$20.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.1% |
| 2 | Technology | 15.48% |
| 3 | Financials | 15.36% |
| 4 | Consumer Discretionary | 7.61% |
| 5 | Communication Services | 7.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CST
1101
DELISTED
CST Brands, Inc.
CST
| $492K | 0.01% |
12,591
-585
| -4% | -$24.4K |
|
1102
Vanda Pharmaceuticals
VNDA
$312M
| $491K | 0.01% |
38,672
-2,413
| -6% | -$26K |
|
|
JOY
1103
DELISTED
Joy Global Inc
JOY
| $491K | 0.01% |
13,573
-3,042
| -18% | -$122K |
|
|
FLIR
1104
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $490K | 0.01% |
15,888
-4,469
| -22% | -$139K |
|
|
AMSG
1105
DELISTED
Amsurg Corp
AMSG
| $489K | 0.01% |
6,987
-2,468
| -26% | -$165K |
|
1106
Abercrombie & Fitch
ANF
$4.17B
| $488K | 0.01% |
22,666
+8,384
| +59% | +$185K |
|
1107
Burlington
BURL
$22B
| $487K | 0.01% |
9,516
+3,980
| +72% | +$213K |
|
1108
Worthington Enterprises
WOR
$2.76B
| $487K | 0.01% |
26,297
-7,780
| -23% | -$133K |
|
|
RGLS
1109
DELISTED
Regulus Therapeutics
RGLS
| $486K | 0.01% |
369
+5
| +1% | +$8.07K |
|
|
TRAK
1110
DELISTED
DEALERTRACK TECHNOLOGIES, INC. COM STK
TRAK
| $485K | 0.01% |
7,729
-3,820
| -33% | -$170K |
|
1111
Murphy USA
MUSA
$11.3B
| $484K | 0.01% |
8,672
-318
| -4% | -$20K |
|
1112
Leidos
LDOS
$14.1B
| $481K | 0.01% |
11,919
-599
| -5% | -$25.2K |
|
|
MDRX
1113
DELISTED
Veradigm Inc. Common Stock
MDRX
| $481K | 0.01% |
35,160
-1,600
| -4% | -$21.6K |
|
|
PGNX
1114
DELISTED
Progenics Pharmaceuticals Inc
PGNX
| $481K | 0.01% |
64,436
-5,042
| -7% | -$30.5K |
|
|
ALE
1115
DELISTED
Allete
ALE
| $480K | 0.01% |
10,343
-1,116
| -10% | -$55.5K |
|
|
CLGX
1116
DELISTED
Corelogic, Inc.
CLGX
| $480K | 0.01% |
12,093
-908
| -7% | -$34.7K |
|
|
ENH
1117
DELISTED
Endurance Specialty Holdings Ltd
ENH
| $480K | 0.01% |
7,310
-305
| -4% | -$19K |
|
|
PETX
1118
DELISTED
Aratana Therapeutics, Inc.
PETX
| $478K | 0.01% |
31,634
-1,873
| -6% | -$27K |
|
1119
EnerSys
ENS
$6.95B
| $477K | 0.01% |
6,782
-3,401
| -33% | -$233K |
|
1120
John Wiley & Sons Class A
WLY
$2.52B
| $477K | 0.01% |
8,767
+117
| +1% | +$6.79K |
|
1121
New York Times
NYT
$11.6B
| $476K | 0.01% |
34,854
-10,543
| -23% | -$145K |
|
1122
MSC Industrial Direct
MSM
$7.02B
| $473K | 0.01% |
6,782
-564
| -8% | -$40.1K |
|
|
SWI
1123
DELISTED
SOLARWINDS INC COM STK (DE)
SWI
| $472K | 0.01% |
10,235
-755
| -7% | -$37.1K |
|
|
CVSA
1124
Covista Inc
CVSA
$3.94B
| $470K | 0.01% |
15,691
+7,544
| +93% | +$249K |
|
1125
Brinker International
EAT
$8.02B
| $470K | 0.01% |
8,157
-800
| -9% | -$45.8K |
|
Similar funds
ProShare Advisors's Q2 2015 Portfolio in Review
As of Q2 2015, ProShare Advisors held 1,950 positions worth $7.23B, down 15% from $8.49B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
ProShare Advisors withdrew a net $1.29B in Q2 2015, closing 301 positions and reducing 1,428 holdings. Its most notable exit was PHARMACYCLICS INC, an estimated $16.5M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Technology and Financials.
Against the trend, ProShare Advisors opened a new position in Uniti Group worth $1.66M.
- ProShare Advisors's largest Q2 2015 buy was Uniti Group: 67,007 shares worth $1.66M.
- ProShare Advisors added most to Equinix in Q2 2015, an estimated $4.63M increase.
- ProShare Advisors's biggest Q2 2015 reduction was Apple, cutting an estimated $94.7M.
- ProShare Advisors fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $16.5M.
- ProShare Advisors's ten largest holdings make up 18% of its $7.23B portfolio in Q2 2015.
- ProShare Advisors opened 32 new positions and closed 301 in Q2 2015.
- ProShare Advisors's portfolio value fell 15% quarter-over-quarter to $7.23B.
Based on ProShare Advisors's 13F filing for Q2 2015, filed 11 Aug 2015.